Arbutus Biopharma Corp
ABUS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001447028
No open-market purchases or sales by Arbutus Biopharma Corp insiders were filed in the last 90 days; 176 institutions reported holding it in 13F filings for Q2 2026, worth $674.9M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Arbutus Biopharma Corp changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 144 | 154 | +10 |
| Shares | 101.1M | 104.1M | +2.98M (+2.9%) |
| Value | $389.2M | $340.3M | −$48.9M (−12.6%) |
New holders (23)
Institutions that held Arbutus Biopharma Corp at the end of Q4 2024 but not at the end of Q3 2024.
Sold out (13)
Institutions that held Arbutus Biopharma Corp at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Sherbrooke Park Advisers LLC | 67,455 | $259.7K |
| Jane Street Group, LLC | 66,910 | $257.6K |
| Cetera Investment Advisers | 54,357 | $209.3K |
| Options Solutions, LLC | 40,932 | $157.6K |
| GTS Securities LLC | 28,817 | $110.9K |
| State of Wyoming | 15,944 | $61.4K |
| Helen Stephens Group, LLC | 13,000 | $50.0K |
| nVerses Capital, LLC | 12,400 | $47.7K |
| American Century Companies Inc | 10,660 | $41.0K |
| Dynamic Wealth Strategies, LLC | 6,300 | $24.0K |
| Capital Performance Advisors LLP | 545 | $2.10K |
| Aster Capital Management (DIFC) Ltd | 130 | $501 |
| Federated Hermes, Inc. | 3 | $12 |